| Financial Year |
March 31 2023 |
| Monetary Funds |
865,379,745.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
149,561,646.87 |
| Accounts Receivable |
643,781,074.77 |
| Advances to Suppliers |
246,762,230.94 |
| Other Receivables |
29,627,448.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
353,361,289.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,393,537.67 |
| Total Current Assets |
2,456,840,881.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
181,765,850.70 |
| Investment Properties |
16,484,721.99 |
| Fixed Assetes |
935,111,582.75 |
| Under-construction Projects |
7,374,786.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,687,063.08 |
| R&D expenses |
2,320,532.56 |
| Goodwill |
754,457,167.13 |
| Long-Term Deferred and Prepaid Expenses |
38,913,770.22 |
| Deferred Income Tax Assets |
20,066,058.75 |
| Other Non-Current Assets |
30,473,360.19 |
| Sub-Total of Non-Current Assets |
2,877,872,463.84 |
| Total Assets |
5,334,713,345.48 |
| Short-Term Loans |
505,624,578.64 |
| Trading Financial liabilities |
284,658.04 |
| Notes Payable |
288,327,994.05 |
| Accounts Payable |
528,687,298.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,331,315.49 |
| Taxes Payable |
24,224,163.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,109,124.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,730,199.34 |
| Other Current Liabilities |
85,304,159.38 |
| Sub-Total of Current Liabilities |
1,572,152,874.96 |
| Long-term Loans |
56,006,083.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
78,643,424.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
138,272,939.95 |
| Total Liabilities |
1,710,425,814.91 |
| Paid-In Capital(Or Share Stock) |
412,113,346.00 |
| Capital Surplus |
1,472,038,062.47 |
| Surplus Reserve |
77,173,546.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,432,105,401.33 |
| Minority Stockholder's Interest |
174,202,621.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,450,084,908.76 |
| Owner's Equity（Stockholder's Equity） |
3,624,287,530.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,334,713,345.48 |
